People with hard-to-treat asthma often have to use medicines such as systemic steroids that broadly suppress the immune ...
Hosted on MSN
Finding the right asthma inhaler for you
New triple therapy: The FDA approved AstraZeneca’s Breztri Aerosphere for asthma patients 12 and older, offering a single inhaler combining ICS/LABA with a LAMA for maintenance treatment. Device ...
More than one million people in England are now using a new style of asthma inhaler that both prevents and relieves symptoms, ...
The FDA has approved AstraZeneca’s Breztri Aerosphere as the first maintenance triple therapy for asthma in patients aged 12 and older. The inhaler combines an inhaled corticosteroid, a long-acting ...
Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma saved money by improving outcomes, according to a meta-analysis. While SMART is recommended by guidelines, ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Following the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont ® Scientific Limited sponsored an informative webinar by Intermedical ...
Health chiefs have issued a call to anyone using the medication to treat asthma attacks ...
Asthma affects millions of people across the country, including over 4 million kids. Using asthma medicines correctly is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results